Patents by Inventor Carlos Fernandez

Carlos Fernandez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140257897
    Abstract: A system for monitoring an availability status of responder personnel comprises a server and a plurality of electronic devices. The server is configured to maintain a list of responder personnel names and an availability status associated with each name. The server executes a server application which displays a first web page including a first on-screen availability object for establishing the availability status of a responder, such that activating the first on-screen availability object establishes the availability status of the responder as of the moment the first on-screen availability object is activated. The electronic devices are configured to communicate with the server.
    Type: Application
    Filed: March 5, 2013
    Publication date: September 11, 2014
    Inventors: Carlos Fernandez, Jr., Stephen B. Owens
  • Publication number: 20140193564
    Abstract: Food products prepared from whole grain oat flour having soluble components. The soluble whole oat flour maintains its standard of identity as whole grain and thus has the characteristics of whole grain oats. Aspects of the present invention relate to the use of the soluble oat flour in liquid food products such as beverages, semi-solid food products such as yogurt, and solid food products such as bakery items in order to provide enhanced health benefits.
    Type: Application
    Filed: March 13, 2014
    Publication date: July 10, 2014
    Applicant: The Quaker Oats Company
    Inventors: Gary D. Carder, Yongsoo Chung, Ronald G. Deutsch, Juan Carlos Fernandez Feito, Justin French, Ursula Vanesa La Ma, Mayte Lee, Margaret J. Miller, Holly Ramage
  • Publication number: 20140193563
    Abstract: Food products prepared from whole grain oat flour having soluble components. The soluble whole oat flour maintains its standard of identity as whole grain and thus has the characteristics of whole grain oats. Aspects of the present invention relate to the use of the soluble oat flour in liquid food products such as beverages, semi-solid food products such as yogurt, and solid food products such as bakery items in order to provide enhanced health benefits.
    Type: Application
    Filed: March 13, 2014
    Publication date: July 10, 2014
    Applicant: The Quaker Oats Company
    Inventors: Gary D. Carder, Yongsoo Chung, Ronald G. Deutsch, Juan Carlos Fernandez Feito, Justin French, Ursula Vanesa La Ma, Mayte Lee, Margaret J. Miller, Holly Ramage
  • Publication number: 20140080899
    Abstract: The inhibition of miRNA miR-33 is shown to promote the polarization of macrophages from an M1 to an M2 phenotype. MiR-33 inhibitors are therefore useful for treating inflammation in subjects. Endogenous microRNAs can be silenced using antagomirs. The miR-33 inhibitor is preferably an antagomir having a single-stranded nucleic acid sequence that is complementary to at least 12 contiguous nucleotides in miR-33 and therefore forms a duplex with miR-33 under physiological conditions.
    Type: Application
    Filed: April 30, 2012
    Publication date: March 20, 2014
    Applicant: NEW YORK UNIVERSITY
    Inventors: Kathryn J. Moore, Katey J. Rayner, Frederick Sheedy, Carlos Fernandez-Hernando, Yajaira Suarez
  • Publication number: 20130150431
    Abstract: The miRNA miR-33 is shown to inhibit the expression of carnitine O-octaniltransferase (CROT), Carnitine palmitoyltransferase 1A (CPT1a) and hydroxyacyl-CoA-dehydrogenase (HADHB), reduce fatty acid oxidation in hepatic cells, and target the insulin receptor substrate 2 (IRS-2) independent of its ability to elevating plasma high density lipoprotein (HDL) levels. MiR-33 inhibitors are also shown to increase cholesterol efflux from peripheral cells, such as cholesterol-laden macrophages present in atherosclerotic plaques. Compositions and methods are therefore provided for treating or preventing metabolic syndrome and atherosclerosis using miR-33 inhibitors. The miR-33 inhibitors are preferably antagomirs having a single-stranded nucleic acid sequence that is complementary to at least 12 contiguous nucleotides in miR-33 and therefore forms a duplex with miR-33 under physiological conditions.
    Type: Application
    Filed: August 26, 2011
    Publication date: June 13, 2013
    Applicant: NEW YORK UNIVERSITY
    Inventors: Carlos Fernandez-Hernando, Kathryn J. Moore, Yajaira Suarez, Katey J. Rayner
  • Publication number: 20130143838
    Abstract: The present invention relates to a novel complex, obtainable by mixing hyaluronic acid or a salt thereof and chondroitin sulphate or a salt thereof, and forming an aqueous solution of said mixture, which is further subjected to a drying process. The invention also relates to various compositions and formulations comprising the complex of the invention, process for obtaining said complex and uses thereof.
    Type: Application
    Filed: November 21, 2012
    Publication date: June 6, 2013
    Applicant: QUIMERA INGENIERIA BIOMEDICA, S.L.
    Inventors: Julian AGUT SANCHEZ, Carlos FERNANDEZ NAVARRO, Joan COS TRULLAS, Laura OCANA SAFONT
  • Publication number: 20130108140
    Abstract: A method for analysis of 2-D gel images obtained using electrophoresis. More particularly, a molecular block-matching method for establishing the correspondence between protein spots in a diagnostic-test image and protein spots in a reference image. Individual protein spot matching is performed, thereby removing the need for alignment of the entire reference and test images and permitting automatic labeling of individual protein spots. The method for analysis of 2-D gel images is fully automated, thus making it ideally suited for protein information retrieval systems.
    Type: Application
    Filed: April 24, 2012
    Publication date: May 2, 2013
    Applicants: UNIVERSIDADE DE A CORUNA, FUNDACION CHUAC, SERGAS
    Inventors: Alejandro Celestino Pazos Sierra, Julián Alfonso Dorado de la Calle, Francisco Blanco García, Javier Pereira Loureiro, Juan Ramón Rabuñal Dopico, Cristina Ruiz Romero, Jose Antonio Seoane Fernández, Ana Maria Freire Veiga, Enrique Fernández Blanco, Alvaro Rodriguez Tajes, Carlos Fernandez Lozano, Ana Belén Porto Pazos, Cristian Robert Munteanu
  • Publication number: 20130098491
    Abstract: Pressure compensation device (100) deployed in an element that contains a flammable substance that compensates pressures between interior (101) of the element and exterior atmosphere (102) in which said element is deployed, by means of a continuous primary circulation (300) of air through primary channel (103) in said device (110) that communicates interior (100) and exterior (102) of the element, further comprising a secondary channel (104) integrated in the device (100) itself, communicating interior (102) and exterior (102) of the element, comprising said secondary channel (104) in the interior zone of the element a sheet (105) such that, in the event primary continuous circulation (300) of air through primary channel (103) is interrupted, said continuous circulation continues through secondary circulation (400) of air to interior (101) of the element, this secondary circulation (400) of air being capable of breaking sheet (105) of secondary channel (104).
    Type: Application
    Filed: January 18, 2012
    Publication date: April 25, 2013
    Applicant: AIRBUS Operations S.L.
    Inventors: Juan Zuniga Sagredo, Carlos Fernandez Alonso, Ignacio Jorge Outon Hernandez
  • Publication number: 20130017300
    Abstract: A process for preparing an oat and milk beverage includes processing taking place under chilled conditions. Moreover, the oat product used in accordance with aspects of this invention is hydrolyzed oat flour.
    Type: Application
    Filed: July 12, 2012
    Publication date: January 17, 2013
    Applicant: PEPSICO, INC.
    Inventors: Cristina Avila, Laura Maria Pires Blasi, Juan Carlos Fernandez, Renee Hamaoui, Mayte Lee
  • Publication number: 20120129855
    Abstract: A compound of the formula (I): wherein: A and B together represent an optionally substituted, fused aromatic ring; X and Y are selected from CH and CH, CF and CH, CH and CF and N and CH respectively; RC is selected from H, C1-4 alkyl; and R1 is selected from C1-7 alkyl, C3-20 heterocyclyl and C5-20 aryl, which groups are optionally substituted; or RC and R1 together with the carbon and oxygen atoms to which they are attached form a spiro-C5-7 oxygen-containing heterocyclic group, which is optionally substituted or fused to a C5-7 aromatic ring.
    Type: Application
    Filed: January 30, 2012
    Publication date: May 24, 2012
    Inventors: Keith Allan Menear, Muhammad Hashim Javaid, Sylvie Gomez, Marc Geoffrey Hummersone, Carlos Fernandez Lence, Niall Morrison Barr Martin, David Alan Rudge, Craig Anthony Roberts, Kevin Blades
  • Patent number: 8168872
    Abstract: A saxophone having a body, a neck including a plurality of keys mounted thereon, each of said keys including an actuating surface and a bell including a valve protector, the improvement comprising a system for controlling the tension and travel of a saxophone player's fingers of both hands with a right hand device and a left hand device. The right hand device has an anchorage assembly mounted to the valve protector and a travel stopper elongated portion integrally extending from the anchorage assembly and kept at a substantially parallel and spaced apart relationship with respect to an actuating surface's plurality of keys thereby limiting the extension movement of a user's fingers as he or she actuates the keys. The left hand device includes an elongate stopper member with anchorage assemblies at its ends. The left hand device is rotatably mounted to facilitate its storage in storage cases.
    Type: Grant
    Filed: May 17, 2010
    Date of Patent: May 1, 2012
    Inventor: Carlos Fernandez
  • Publication number: 20120053227
    Abstract: The miRNA miR-33 is shown to inhibit the expression of carnitine O-octaniltransferase (CROT), Carnitine palmitoyltransferase 1A (CPT1a) and hydroxyacyl-CoA-dehydrogenase (HADHB), reduce fatty acid oxidation in hepatic cells, and target the insulin receptor substrate 2 (IRS-2) independent of its ability to elevating plasma high density lipoprotein (HDL) levels. MiR-33 inhibitors are also shown to increase cholesterol efflux from peripheral cells, such as cholesterol-laden macrophages present in atherosclerotic plaques. Compositions and methods are therefore provided for treating or preventing metabolic syndrome and atherosclerosis using miR-33 inhibitors. The miR-33 inhibitors are preferably antagomirs having a single-stranded nucleic acid sequence that is complementary to at least 12 contiguous nucleotides in miR-33 and therefore forms a duplex with miR-33 under physiological conditions.
    Type: Application
    Filed: August 26, 2011
    Publication date: March 1, 2012
    Inventors: Carlos Fernández-Hernando, Kathryn J. Moore, Yajaira Suárez, Katey J. Rayner
  • Publication number: 20110149593
    Abstract: The invention relates to a fiber optic lighting system for drink taps. The inventive system consists of an external light-emitting core from which light is conveyed by means of fiber optic into a drink tap comprising a rigid plate to which the fiber optic is fixed. The aforementioned plate is placed inside a structure which is made from a light-diffusing material and which is covered with a light-refracting resin. The external light-emitting core is formed by a ventilator (6), inlet (8) and outlet (7) ventilation conduits, a halogen lamp (1), a flashing and/or colored disk (2) which rotates by means of a motor (3) and a harness of fiber optic cables (4) which are joined at an optical port (5).
    Type: Application
    Filed: May 19, 2006
    Publication date: June 23, 2011
    Inventor: Carlos Fernandez-Espana Garcia
  • Publication number: 20110062718
    Abstract: This invention is a unique ‘Generator Platform and Drive Assembly for Alternative Power Production from Aermotor® and Similar Design Windmills”. Used to convert or retrofit prior art water pump windmills to produce renewable energy, mainly in the form of electricity. This invention incorporates the attributes of the prior art windmill's high torque, low rpm, low wind, multiple sail design with a unique, versatile “Generator Platform and Drive Assembly’. The power from the sails is transferred and amplified by the invention's custom design ‘split’ sprocket/pulley specifically machined to attach to the Aermotor® prior art sail/brake hub, which then turns the generator attached to the ‘generator platform’, by means of a belt or chain drive.
    Type: Application
    Filed: September 17, 2009
    Publication date: March 17, 2011
    Inventor: Carlos Fernandez-Bueno
  • Publication number: 20090305987
    Abstract: The invention provides a method of inducing ?-cell neogenesis from epithelial cells. The method includes the step of exposing epithelial cells that have a disrupted G1-S cell cycle transition to a hedgehog protein in an amount effective to stimulate ?-cell neogenesis from the epithelial cells. Cells resulting from the method are insulin-positive and express pancreatic progenitor cell markers including Pdx-1 and ngn3. ?-cell population expansion is observed when the method is carried out in either in vitro or in vivo settings.
    Type: Application
    Filed: May 18, 2009
    Publication date: December 10, 2009
    Applicant: The General Hospital Corporation
    Inventors: Sarah P. Thayer, Jennifer LaFemina Fowler, Andrew L. Warshaw, Carlos Fernandez-del Castillo
  • Publication number: 20090296421
    Abstract: The invention relates to a support module including a fiber optic lighting system for bottles, characterized by an internal or external light-emitting core from which light is conveyed by means of fiber optic into a bottle that is suspended by a fixing system from a hollow element having a triangular cross-section. The aforementioned fixing system comprises a hollow screw into which the optic fiber is introduced and said fixing system is placed inside a bottle and fixed to the triangular base.
    Type: Application
    Filed: May 19, 2006
    Publication date: December 3, 2009
    Inventor: Carlos Fernandez-España
  • Publication number: 20080138875
    Abstract: The present invention provides method to produce fungi biomass from mycelia comprising inoculating differentiated cells or mycelia into a culture medium which contains at least NaNO3, KH2PO4, MgSO4, KCl, and a source of carbon. This method also includes incubation of said culture under a specific wave length in a specially designed tridimensional closed system or incubator in which all the internal surfaces have all the characteristics of a mirror.
    Type: Application
    Filed: December 8, 2006
    Publication date: June 12, 2008
    Inventors: Lucia Atehortua, Paola Andrea Zapata, Diego Fernando Rojas, David Alexander Ranirez, Carlos Fernandez
  • Publication number: 20070129751
    Abstract: Devices, systems and methods wherein a dilator, such as a balloon or other expandable member, is positionable within the frontal sinus ostium and adjacent frontal recess and useable to dilate the frontal sinus ostium and substantially all of the frontal sinus recess without requiring repositioning and repeated re-expansion of the dilator. One balloon catheter device of the invention comprises a catheter body that is less than about 50 cm in length (and in some embodiments less than 25 cm in length and a semi-compliant or non-compliant balloon on the catheter body. The balloon may have a working length of about 12 mm to about 30 mm and a width at its widest point when fully inflated of about 2 mm to about 7 mm. Such balloon may be constructed to withstand inflation pressures of about 12 atmospheres. In some embodiments, the dilator is advanced through or over a guide (e.g., guidewire or guide catheter) that has a preformed shape.
    Type: Application
    Filed: February 16, 2006
    Publication date: June 7, 2007
    Applicant: Acclarent, Inc.
    Inventors: Ketan Muni, Carlos Fernandez, Joshua Makower, John Chang, William Facteau
  • Patent number: 6842704
    Abstract: A tumor necrosis factor-? converting enzyme (TACE) is produced, purified, and crystallized. The three-dimensional coordinates of the crystal are obtained by X-ray diffraction. The coordinates can be recorded on a computer readable medium, or are part of a video memory, where they can be used as part of a system for studying for studying TACE. The coordinates are also used in designing, screening, and developing compounds that associate with TACE.
    Type: Grant
    Filed: February 4, 1999
    Date of Patent: January 11, 2005
    Assignees: Immunex Corporation, Max-Planck-Institute for Biochemistry, Wyeth
    Inventors: Roy A. Black, Raymond James Paxton, Wolfram Bode, Klaus Maskos, Carlos Fernandez-Catalan, James Ming Chen, Jeremy Ian Levin
  • Patent number: D706283
    Type: Grant
    Filed: January 17, 2013
    Date of Patent: June 3, 2014
    Assignee: Metalast, S.A.
    Inventors: Domingo Pedraza Padilla, Carlos Fernández Cantalejo, Frederic Fort Viader